Victory Portfolios IV has disclosed its latest financial details in a recent NPORT-P filing, indicating a total net asset value of approximately $7.85 billion. This report, filed on October 29, 2026, is crucial as it showcases the company's financial health and asset management capabilities.
The filing reveals that Victory Portfolios IV, incorporated in Delaware, operates primarily in the investment sector. The company is known for its diverse portfolio, including the Victory Pioneer Multi-Asset Ultrashort Income Fund, which features various classes of shares aimed at different investor needs.
Background
Victory Portfolios IV, identified by CIK 0002042316, is an investment company that focuses on managing a range of funds. The company has been active in filing reports with the SEC, with its most recent submissions including several NPORT-P forms on October 29, 2026. The firm is dedicated to providing investors with a transparent view of its financial performance and asset allocation.
What the Filing Says
The recent NPORT-P filing indicates that as of August 31, 2026, Victory Portfolios IV reported total assets of approximately $8.17 billion and total liabilities of about $325 million. The net assets, therefore, stand at around $7.85 billion. This robust asset base reflects the company's strong position in the investment management landscape.
Impact
This filing may significantly impact investors and stakeholders within the investment management industry. By providing detailed insights into its financial standing, Victory Portfolios IV sets a benchmark for transparency and accountability that competitors may need to match. The report's figures could influence investor confidence and decisions regarding asset allocations in similar funds.
What's Next
The filing does not specify what happens next, leaving stakeholders to await further updates from the company regarding its investment strategies and future performance metrics.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






